Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Plus Therapeutics Reports Promising Phase 1 Trial Results for Rhenium (186Re) Obisbemeda in Leptomeningeal Disease with Plans for Expanded Trials in 2025

Plus Therapeutics reports positive Phase 1 trial results for Rhenium (186Re) Obisbemeda in breast cancer-related leptomeningeal disease.Quiver AI SummaryPlus Therapeutics, Inc. has shared promising results...

PSTV : 1.0800 (unch)
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

PSTV : 1.0800 (unch)
Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium

PSTV : 1.0800 (unch)
Plus Therapeutics, Inc. Renews Master Services Agreement with Telix IsoTherapeutics to Secure Supply of Radiotherapeutic Isotope Re-186

Plus Therapeutics renews agreement with Telix IsoTherapeutics for cGMP Re-186 supply, supporting clinical trial demands for cancer therapy.Quiver AI SummaryPlus Therapeutics, Inc. has renewed its Master...

PSTV : 1.0800 (unch)
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply

PSTV : 1.0800 (unch)
Plus Therapeutics Reports Promising Phase 1 Trial Results of Rhenium (186Re) Obisbemeda for Leptomeningeal Metastases, Secures FDA Approval for Expanded Studies

Rhenium (186Re) Obisbemeda shows promising results for leptomeningeal metastases, with favorable survival rates and FDA trial approval.Quiver AI SummaryPlus Therapeutics, Inc. announced the positive results...

PSTV : 1.0800 (unch)
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference

PSTV : 1.0800 (unch)
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSideâ„¢ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases

PSTV : 1.0800 (unch)
CNSide Diagnostics Presents Key Findings on Cerebrospinal Fluid Assay for Leptomeningeal Metastases at 2024 SNO Annual Meeting

CNSide Diagnostics presents findings on mutational changes in CSF for leptomeningeal metastases, aiding treatment selection.Quiver AI SummaryCNSide Diagnostics, a subsidiary of Plus Therapeutics, presented...

PSTV : 1.0800 (unch)
Plus Therapeutics to Present Multi-Institutional Experience Using the CNSideâ„¢ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases

PSTV : 1.0800 (unch)

Barchart Exclusives

2 Dow Stocks to Buy in 2025 That Also Pay Dividends
These dividend-paying stocks could be good additions to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar